gracecast-116_lung-cancer_asco 2012 lc highlights: dr. neal on select trial of tarceva (erlotinib)
Published 11 years ago • 171 plays • Length 4:51Download video MP4
Download video MP3
Similar videos
-
5:13
gracecast-115_lung-cancer_asco 2012 lc highlights: dr. neal on lux-lung 3 trial for advanced nsclc
-
5:11
gracecast-114_lung-cancer_asco 2012 lc highlights: dr. neal on mek inhibitor selumetinib in nsclc
-
20:34
gracecast-118_lung-cancer_asco 2012 lung cancer highlights: question and answer session
-
7:09
gracecast-111_lung-cancer_asco 2012 lc highlights: dr. socinski on tailor trial in advanced nsclc
-
4:30
gracecast-117_lung-cancer_asco 2012 lc highlights: dr. neal on molecular targets in squamous nsclc
-
8:06
gracecast-112_lung-cancer_asco 2012 lc highlights: dr. socinski on key trials in small cell lc
-
7:41
gracecast-113_lung-cancer_asco 2012 lc highlights: dr. neal on anti-pd-1 immunotherapy for nsclc
-
8:38
gracecast-109_lung-cancer_asco 2012 lung cancer highlights: dr. mark socinski on paramount trial
-
16:43
radiant and select: is adjuvant erlotinib effective in early-stage lung cancer?
-
11:13
gracecast-091_lung-cancer_highlights 2011: the egfr axis
-
9:26
adding avastin to tarceva help egfr positive lung cancer patients?
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
23:32
gracecast-077_lung-cancer_asco 2011 highlights - advanced/metastatic nsclc
-
3:36
gracecastuc-018_radiation_safely combine tarceva with brain radiation for lc brain metastases?
-
40:09
gracecast-076_lung-cancer_asco 2011 highlights - sclc, early stage nsclc and mesothelioma
-
4:11
treatment options for newly diagnosed aml: venetoclax and midostaurin - blood cancer onctalk
-
13:40
gracecast-104_lung-cancer_immunotherapy for lung cancer: q and a session
-
4:19
clinical trial spotlight: alchemist for early-stage alk and egfr lung cancer patients
-
2:11
asco lung cancer highlights, pt 13: immune checkpoint inhibitor mpdl3280a in advanced nsclc